Melatonin is a potential inhibitor of ovarian cancer: molecular aspects
Abstract Ovarian cancer is one of the most common causes of morbidity related to gynecologic malignancies. Possible risk factors are including hereditary ovarian cancer, obesity, diabetes mellitus, alcohol consumption, aging, and smoking. Various molecular signaling pathways including inflammation,...
Saved in:
Main Authors: | Hadis Zare (Author), Rana Shafabakhsh (Author), Russel J. Reiter (Author), Zatollah Asemi (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quercetin: a natural compound for ovarian cancer treatment
by: Rana Shafabakhsh, et al.
Published: (2019) -
Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives
by: Alireza Mafi, et al.
Published: (2023) -
Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders
by: Doris Loh, et al.
Published: (2021) -
Melatonin: A Potential Regulator of DNA Methylation
by: Kinga Linowiecka, et al.
Published: (2023) -
Aging-Related Ovarian Failure and Infertility: Melatonin to the Rescue
by: Russel J. Reiter, et al.
Published: (2023)